cp wire

CP Wire Articles

Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.
Chardan Healthcare Acquisition Corp. (NYSE: CHAC, “CHAC”), a special... read more

Mon, 10/28/19 - 10:49 am

TELA Bio filed the paperwork for a $69 Million IPO on 10/15/2019. The Malvern, PA based company makes interwoven biologic tissue devices used in hernia repair and abdominal wall reconstruction.... read more

Wed, 10/16/19 - 10:58 am

Oyster Point Pharma filed the paperwork for $85 Million IPO on 10/4/19. The Princeton,... read more

Mon, 10/7/19 - 10:09 am

Cabaletta Bio filed the paperwork for their $100 Million IPO on 9/30/19. The... read more

Wed, 10/2/19 - 09:42 am

4D Molecular Therapeutics filed the paperwork for a $100 Million IPO on 9/30/19. The Emeryville, CA... read more

Tue, 10/1/19 - 09:30 am

Frequency Therapeutics updated its $123 Million IPO on 9/23/19. The Woburn, Ma based company is focused on on harnessing the body’s innate biology to repair or reverse damage caused by a broad... read more

Tue, 09/24/19 - 09:15 am
As of today Fabrizio Folco assumes management of the company's organization for the Italian market

Catania, September 20, 2019 - SIFI... read more
Fri, 09/20/19 - 10:34 am
Toronto, ON, September 18, 2019 -- ACTO and Teleflex’s Vascular Division won a coveted Brandon Hall Group Bronze award for excellence in the “Best Advance in Learning... read more
Thu, 09/19/19 - 10:51 am

IGM updated its IPO filing on 9/17/19. In the amended filing, the Mountain View, CA based biotech said it may raise up to $213 million and offer 10,937,500 shares. IGM will trade on NASDAQ under... read more

Tue, 09/17/19 - 09:42 am

CINs are becoming a primary point of engagement for IDNs and are becoming more crucial to population health management and value-based contracts. To this end, CINs are becoming building blocks for... read more

Mon, 09/16/19 - 12:31 am

Satsuma Pharmaceuticals file the paperwork for an $80 million IPO on 9/11/19. The company is developing a nasal delivery form of dihydroergotamine mesylate (DHE) for treating migraine headaches.... read more

Thu, 09/12/19 - 09:33 am

Azitra, Inc.Appoints Mark Sampson, Ph.D. as Chief Scientific Officer
On 8/27/19, Azitra, Inc., a clinical-stage medical dermatology company addressing severe skin conditions by... read more

Wed, 09/11/19 - 10:42 pm

Monopar filed an amendment to its IPO filing on 9/10/19. It has raised its upper estimate to $46 Million. The company will trade on NASDAQ under the symbol, “MNPR.” See original... read more

Wed, 09/11/19 - 09:34 am
CRESSKILL, N.J., September 5, 2019 /PRNewswire/ -- Vascular Therapies, a clinical stage biotechnology company, is developing Sirogen™, a proprietary sirolimus formulation for intraoperative... read more
Tue, 09/10/19 - 09:37 am

On 9/10/19, Plus Therapeutics filed for a $34 million offering that will consist of Class A units, Class B units, common stock and warrants to purchase common stock. Plus is developing oncology... read more

Tue, 09/10/19 - 09:29 am

On 9/6/19 Aprea Therapeutics https://www.aprea.com filed the paperwork for its IPO. The company anticipates raising up to $86 million. Aprea has facilities in... read more

Mon, 09/9/19 - 09:33 am

On 9/4/19 Enivsta Holdings updated the filing for its upcoming $738 million IPO. The dental supplies and equipment company spun out of Danaher will be comprised of three operating units: Nobel... read more

Wed, 09/4/19 - 09:40 am

On 9/3/19, Turning Point Therapeutics filed the paperwork for a $296 million offering of its common stock. The San Diego based biotech focused on... read more

Tue, 09/3/19 - 04:36 pm

Pfizer biotech spinout, Springworks Therapeutics, updated it IPO filing on 9/3/19. The company will raise up to $143 million and offer 7,352,941 shares... read more

Tue, 09/3/19 - 09:50 am

Veila Bio filed the paperwork for a $150 million IPO on 8/29/19. Viela is a clinical stage biotech focused on developing treatments for severe inflammation and... read more

Fri, 08/30/19 - 09:52 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.